HK Innoen

Business Data, Corporate Office and Headquarter Address

About

HK Innoen is Pharmaceuticals in South Korea that focus on N Corp business. Founded in 1984. They cover business area such as pharmaceutical product.

Business Type

Pharmaceuticals

Country

South Korea

Founded

1984
( 40 years old in 2024 )

Company Focus

N Corp

Website

-

Corporate Office and Headquarter Office address:

100, Eulji-ro
Jung-gu
Seoul, 04551
South Korea

Phone number:

Private

Office Opening Hours*:

Monday 9.30 - 17.00
Tuesday 9.30 - 17.00
Wednesday 9.30 - 17.00
Thursday 9.30 - 17.00
Friday 9.30 - 17.00
Saturday Closed
Sunday Closed

Business Coverage

pharmaceutical product

* We use standard office opening hours in near HK Innoen's location as default value for unknown and outdated data. For more valid info, please verify the info from more trusted sources like GoogleMyBusiness, Yelp, FourSquare or similar services.

HK Innoen Frequently Asked Questions

What or who is HK Innoen?

HK Innoen is Pharmaceuticals business from South Korea that founded in 1984 (40 years old in 2024), HK Innoen business is focusing on N Corp.

Where is HK Innoen headquarter and corporate office address?

HK Innoen headquarter office and corporate office address is located in 100, Eulji-ro Jung-gu Seoul, 04551 South Korea.

Where is HK Innoen country origins?

HK Innoen was founded in South Korea.

What is N Corp business focus on?

In 2024, HK Innoen is currently focus on N Corp sector.

N Corp Business Interest from Google Trend

Above is snippet of Google Trends for "N Corp" term, if you have problem loading the snippet, please visit here: Google Trend.

Disclaimer: This website is not affiliated with HK Innoen, any government agency, does not create this data, vouch for its accuracy, or guarantee that it is the most recent data available. The data displayed is available through open government websites and public online directory. This website expressly disclaims the accuracy, adequacy, or completeness of any data and shall not be liable for any errors, omissions or other defects in, delays or interruptions in such data, or for any actions taken in reliance thereon.